Comparably, prostates of Pten deletion, the most well-studied GEM model of prostate cancer, exhibit increased basal marker expression, lose Nkx3.1 expression, and are castration resistant de novo (26–28, 60). The gene discussed is PTEN; the disease is prostate carcinoma.